Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,386 | 20,450 | 28,677 | 34,859 | 13,462 |
| Marketable Securities | 48,961 | 51,074 | 51,732 | 42,553 | 19,782 |
| Receivables | 73,708 | 65,322 | 60,137 | 63,795 | 76,693 |
| Inventories | 42,864 | 42,473 | 42,110 | 42,007 | 44,623 |
| TOTAL | $191,168 | $185,903 | $188,774 | $193,979 | $165,280 |
| Non-Current Assets | |||||
| PPE Net | 15,900 | 19,306 | 20,166 | 20,785 | 20,873 |
| Other Non-Current Assets | 11,068 | 12,678 | 13,566 | 14,435 | 15,071 |
| TOTAL | $26,968 | $31,984 | $33,732 | $35,220 | $35,944 |
| Total Assets | $218,136 | $217,887 | $222,506 | $229,199 | $201,224 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,226 | 837 | 3,240 | 1,860 | 1,957 |
| Accrued Expenses | 24,639 | 27,590 | 31,515 | 35,116 | 29,737 |
| TOTAL | $80,317 | $75,378 | $79,685 | $79,745 | $86,722 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,634 | 24,447 | 24,263 | 24,023 | N/A |
| Other Non-Current Liabilities | 151,125 | 151,828 | 152,531 | 153,217 | 153,786 |
| TOTAL | $175,759 | $176,275 | $176,794 | $177,240 | $153,786 |
| Total Liabilities | $256,076 | $251,653 | $256,479 | $256,985 | $240,508 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 151,668 | 150,653 | 150,329 | 150,073 | 140,759 |
| Common Shares | 1,516 | 1,504 | 1,503 | 1,411 | 1,199 |
| Retained earnings | -1,918,409 | -1,909,174 | -1,906,014 | -1,895,290 | -1,870,282 |
| Other shareholders' equity | -8 | -6 | 13 | -1 | -6 |
| TOTAL | $-37,940 | $-33,766 | $-33,973 | $-27,786 | $-39,284 |
| Total Liabilities And Equity | $218,136 | $217,887 | $222,506 | $229,199 | $201,224 |